Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema

NCT01823081 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.

NCT NCT01823081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01823081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
Lead sponsor
Shahid Beheshti University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2015
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema